Skip to main content

Magnesium (MgSO₄) in Emergency and Critical Care: Complete Guide for Clinicians

 


Magnesium (MgSO₄) in Emergency and Critical Care: Complete Guide for Clinicians

Magnesium sulphate (MgSO₄) is one of the most versatile and lifesaving medications used in emergency medicine, cardiology, and critical care. Despite being inexpensive and widely available, it is often under-utilized or incorrectly dosed. This comprehensive guide covers everything you need to know about its indications, dosing strategies, preparation, mechanisms, side effects, and the clinical scenarios where it truly saves lives.


Magnesium plays a central role in neuromuscular stability, cardiac conduction, bronchial smooth muscle relaxation, and cellular enzymatic processes. In acute care settings, timely administration can improve outcomes and even reverse life-threatening arrhythmias.



---


What is Magnesium Sulphate (MgSO₄)?


Magnesium sulphate heptahydrate is a formulation where 1 gram ≈ 4 mmol of Mg²⁺. In hospital practice, it is commonly stocked as Magnesium sulphate 50% solution, where:


10 ml contains 20 mmol of Mg²⁺ (equivalent to 5 g MgSO₄).



This concentrated form requires dilution prior to administration depending on the clinical indication.



---


Key Clinical Indications for Magnesium Use


1. Severe Hypomagnesaemia


Hypomagnesaemia can lead to:


Ventricular arrhythmias


QT prolongation


Refractory hypokalaemia


Muscle weakness and tetany



Infusion dose:

2–4 g (8–16 mmol Mg²⁺) infused over 60 minutes.


Magnesium correction is essential when potassium or calcium correction is failing, as magnesium deficiency prevents cellular uptake of both electrolytes.



---


2. Torsades de Pointes (TDP)


Torsades de pointes is a polymorphic ventricular tachycardia associated with prolonged QT interval. Magnesium works even when the serum level is normal because it stabilizes myocardial electrical activity.


Bolus dose:

2 g (8 mmol) over 10 minutes.

May repeat once if arrhythmia persists.


Mechanism:


Shortens QT interval


Suppresses early after-depolarisations


Helps terminate TDP and prevent recurrence



Even in drug-induced QT prolongation, magnesium remains a first-line therapy.



---


3. Acute Severe Asthma


Magnesium is a potent smooth muscle relaxant and reduces airway hyperresponsiveness.


Infusion dose:

1.2–2 g over 20 minutes.


Benefits:


Reduces hospitalization


Improves airflow


Enhances response to bronchodilators



It is particularly useful in patients who are not responding to repeated nebulisations.



---


Pharmacological Mechanism of Action


Magnesium acts on multiple systems simultaneously:


Cardiac System


Stabilises myocardial cell membranes


Inhibits calcium influx


Reduces arrhythmogenicity



Respiratory System


Relaxes bronchial smooth muscle


Decreases acetylcholine release at neuromuscular junctions



Neuromuscular System


Acts as a physiological calcium antagonist


Reduces neuroexcitation and muscle spasm



Electrolyte Role


Enhances renal conservation of potassium


Needed for PTH release and calcium metabolism



This multi-system action explains why magnesium is so beneficial in arrhythmias, asthma, eclampsia, and metabolic derangements.



---


Dose and Administration (Practical Guide)


Hypomagnesaemia


2–4 g (8–16 mmol) over 1 hour



Torsades de Pointes


2 g IV over 10 minutes


Repeat once if needed



Acute Severe Asthma


1.2–2 g over 20 minutes




---


How to Prepare Magnesium for Clinical Use


For a 2 g dose:


1. Draw 4 ml of magnesium sulphate 50% (equals 2 g / 8 mmol).



2. Dilute in 100 ml Normal Saline.



3. Infuse using a pump at the rate appropriate for your indication.




This ensures accurate delivery and reduces risk of side effects.



---


Monitoring During Magnesium Administration


Magnesium must be infused in a monitored environment such as a resuscitation bay.


Monitoring includes:


Continuous ECG


Blood pressure


Respiratory status


Urine output



Watch for signs of magnesium toxicity:


Loss of patellar reflexes


Weakness


Drowsiness


Warmth/flushing


Nausea


Double vision


Slurred speech



Severe toxicity may lead to respiratory depression or hypotension; calcium gluconate is the antidote.



---


Additional Drugs Required in Associated Conditions


In Torsades de Pointes


Magnesium is essential, but you may also need:


Intravenous potassium if the patient is hypokalaemic


Correction of underlying triggers (QT-prolonging drugs, electrolyte imbalance)


Consideration of temporary pacing in refractory cases



In Acute Severe Asthma


Administer along with:


Salbutamol and Ipratropium nebulisers


Systemic corticosteroids (prednisolone or hydrocortisone)


IM adrenaline 0.5 mg if anaphylaxis is suspected



Magnesium is an adjunct, not a standalone therapy, in asthma.



---


Advantages of Using Magnesium in Emergency Medicine


Rapid onset of action


Useful even when serum magnesium is normal (e.g., TDP)


Favourable safety profile in controlled settings


Cheap and readily available


Requires no specialized storage


Effective across multiple systems




---


Common Myths and Clarifications


Myth: Magnesium works only when levels are low.


Fact: Magnesium works in Torsades even with normal levels.


Myth: All magnesium doses must be slow.


Fact: In arrhythmias like TDP, a fast bolus is required.


Myth: Oral magnesium is enough.


Fact: Oral replacement is too slow and unreliable in acute settings.



---


Clinical Tips and Pitfalls


Always assess for hypokalaemia and hypocalcaemia—these often coexist.


Deep tendon reflexes begin to depress at magnesium levels > 4 mmol/L.


Rapid IV push outside Torsades management may cause hypotension.


Severe asthma patients benefit most when magnesium is given early.


Avoid mixing magnesium with bicarbonate in the same line—precipitation risk.




---


References (Recommended)


1. European Resuscitation Council (ERC) Guidelines for Advanced Life Support.



2. Global Initiative for Asthma (GINA) Management Guidelines.



3. American Heart Association ACLS Arrhythmia Guidelines.



4. StatPearls: Magnesium Sulfate Pharmacology.



5. British National Formulary (BNF): Magnesium Sulphate IV Use.





---


Final Thoughts


Magnesium sulphate is a powerful, cost-effective, and often lifesaving medication in emergency and critical care. Whether managing a patient in refractory asthma, stabilizing a life-threatening arrhythmia like Torsades de Pointes, or correcting severe electrolyte disturbances, magnesium should always be on your therapeutic radar. Understanding its dosing, dilution, monitoring, and early use can significantly improve patient outcomes.



Comments

Popular posts from this blog

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

  If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

What is Duke treadmill Score (DTS) and How to calculate it?

Watch this simple video on DTS calculation with example case:   Commonly asked questions: How to Calculate Duke treadmill Score? What is DTS? How to risk stratify a patient with ETT (Exercise Tolerance Test)? #Cardiology #Non-Invasive risk Stratification